MYX 2.56% $3.81 mayne pharma group limited

P/E versus competitors: Company currently trading on a forward...

  1. 719 Posts.
    lightbulb Created with Sketch. 38
    P/E versus competitors:
    Company currently trading on a forward P/E of 12.4 times. This is a 30% discount to the average of 19.9 times.
    Over the past two years MYX has traded at an average 20% premium to comps which would imply a P/E of 21.4.

    Price to book value versus competitors
    Company currently trading at Price to Book Value of 1.2x. This is a 48% discount to the average of P/BV of competitors of 2.2 times. Over the past two years MYX has traded at an average 42% P/BV premium to comps. So the difference is currently 89%.

    Looking at just MYX own history by itself.
    P/E ratio average over past two years using forward earnings is 20.2.
    Current P/E of 12.4 is a 38% discount to that average
    Price to book of 1.2 times currently compares to average of 3.2 times. This is a 63% discount.

    If sentiment turns even slightly, this company is due a very healthy uplift in share price.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.